Active You: Walk, Dance, and Tone Your Abs to Reduce Your Risk of Diabetes

N/A Completed NCT06127251

Summary

The phenomenon of physical activity (PA) avoidance in obesity has been detailed in the literature, but there is a lack of programs designed to address the root causes. In addition to common PA barriers such as lack of time, individuals with obesity face weight-related impediments, including stigma, shame, poor fitness, and low exercise self-efficacy, which reduce their engagement in PA. These impediments have been observed in white and minoritized populations. Numerous studies have suggested that individuals with obesity prefer activities that are enjoyable, less exhausting, and conveniently available in settings where they are not exposed to stigma. The studies also point to a need for programs that focus on the general health benefits of PA rather than weight loss, which although desirable, can be elusive. Unmet weight loss expectations contribute to high dropout rates and non-adherence to the prescribed PA regimen among those with obesity. This is particularly consequential for minoritized populations including African Americans who tend to lose less weight in lifestyle interventions but achieve significant improvements in many cardiometabolic outcomes. In this proposal, investi

Participants Enrolled Within 4 Months of Study Opening

4 months after screening procedures start · Participants

Number of Participants Retained in Each Group

12 weeks · Participants

The System Usability Scale

12 weeks · score on a scale

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

• Ignite Pilot: Goal Setting in a Digital Weight Loss Intervention — Stanford University
• Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects — University of Pennsylvania
• Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes — The Cleveland Clinic
• Time Restricted Eating for Weight Loss Maintenance — NYU Langone Health
• Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Effect of PDE5 Inhibition on Adipose Metabolism in Humans — Vanderbilt University Medical Center

All trials